4 research outputs found
Leptospirosis en Corrientes, Argentina
Se realiz贸 una investigaci贸n epidemiol贸gica de Leptospi颅rosis en 92 personas procedentes de la Ciudad de Corrien颅tes, personal de Gendarmer铆a Nacional en su mayor铆a y pobladores civiles minoritariamente y sin antecedentes de enfermedad. Se utiliz贸 Test de Microaglutinaci贸n o MAT y serolog铆a antileptospiras humanas (Bio Rad). Uno de ellos result贸 positivo a grippotyphosa (1 %) lo que se destaca por la baja frecuencia de su relato en Argentina.Se complet贸 el estudio con b煤squeda de leptospiras en cultivos de ri帽ones de roedores, estudiando a 73 (100%) Rattus rattus resultando positivos 23 (31 %) de ellos.
Impact of influenza in the post-pandemic phase: Clinical features in hospitalized patients with influenza A (H1N1) pdm09 and H3N2 viruses, during 2013 in Santa Fe, Argentina
It is important to characterize the clinical and epidemiological pattern of the influenza A (H1N1) pdm09 virus and compare it with influenza A (H3N2) virus, as surveyed in just a few studies, in order to contribute to the implementation and strengthening of influenza control and prevention strategies. The aims in this study were to describe influenza clinical and epidemiological characteristics in hospitalized patients, caused by influenza A (H1N1)pdm09 and influenza A (H3N2) viruses during 2013, in Santa Fe, Argentina. A retrospective study was conducted over 2013 among hospitalized patients with laboratory-confirmed influenza diagnosis. In contrast to patients with influenza A (H3N2) (20.5%), a higher proportion of hospitalizations associated with influenza H1N1pdm were reported among adults aged 35-65 years (42.8%). Of all patients, 73.6% had an underlying medical condition. Hospitalized patients with H1N1pdm were subject to 2.6 (95%CI, 1.0-6.8) times higher risk of severity, than those hospitalized with influenza A (H3N2). This results demonstrate the impact in the post-pandemic era of H1N1pdm virus, with increased risk of severe disease, in relation to H3N2 virus, both viruses co-circulating during 2013
Impact of influenza in the post-pandemic phase: Clinical features in hospitalized patients with influenza A (H1N1) pdm09 and H3N2 viruses, during 2013 in Santa Fe, Argentina
It is important to characterize the clinical and epidemiological pattern of the influenza A (H1N1) pdm09 virus and compare it with influenza A (H3N2) virus, as surveyed in just a few studies, in order to contribute to the implementation and strengthening of influenza control and prevention strategies. The aims in this study were to describe influenza clinical and epidemiological characteristics in hospitalized patients, caused by influenza A (H1N1)pdm09 and influenza A (H3N2) viruses during 2013, in Santa Fe, Argentina. A retrospective study was conducted over 2013 among hospitalized patients with laboratory-confirmed influenza diagnosis. In contrast to patients with influenza A (H3N2) (20.5%), a higher proportion of hospitalizations associated with influenza H1N1pdm were reported among adults aged 35-65 years (42.8%). Of all patients, 73.6% had an underlying medical condition. Hospitalized patients with H1N1pdm were subject to 2.6 (95%CI, 1.0-6.8) times higher risk of severity, than those hospitalized with influenza A (H3N2). This results demonstrate the impact in the post-pandemic era of H1N1pdm virus, with increased risk of severe disease, in relation to H3N2 virus, both viruses co-circulating during 2013
Emerging Hantaviruses in Central Argentina: first case of Hantavirus Pulmonary Syndrome caused by Alto Paraguay Virus and a novel orthohantavirus in Scapteromys aquaticus rodent
Orthohantaviruses are emerging rodent-borne pathogens that cause Hantavirus Pulmonary Syndrome in humans. They have a wide range of rodent reservoir hosts and are transmitted to humans through aerosolized viral particles generated by the excretions of infected individuals. Since the first description of HPS in Argentina, new hantaviruses have been reported throughout the country, most of which are pathogenic to humans. We present here the first HPS case infected with Alto Paraguay virus reported in Argentina. Until now, Alto Paraguay virus was considered a non-pathogenic orthohantavirus since it was identified in a rodent, Holochilus chacarius. In addition to this, with the goal of identifying potential hantavirus host species in the province of Santa Fe, we finally describe a novel orthohantavirus found in the native rodent Scapteromys aquaticus, which differed from other hantaviruses described in the country so far. Our findings implicate an epidemiological warning regarding these new orthohantaviruses circulating in Central Argentina as well as new rodent species that must be considered as hosts from now on.Fil: Bellomo, Carla Mar铆a. Direcci贸n Nacional de Instituto de Investigaci贸n.Administraci贸n Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbr谩n"; ArgentinaFil: Alonso, Daniel Oscar. Direcci贸n Nacional de Instituto de Investigaci贸n.Administraci贸n Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbr谩n"; ArgentinaFil: Ricardo, Tamara. Consejo Nacional de Investigaciones Cient铆ficas y T茅cnicas. Centro Cient铆fico Tecnol贸gico Conicet - Santa Fe; Argentina. Universidad Nacional del Litoral. Facultad de Humanidades y Ciencias. Departamento de Ciencias Naturales; ArgentinaFil: Coelho, Roc铆o Mar铆a. Direcci贸n Nacional de Instituto de Investigaci贸n.Administraci贸n Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbr谩n"; ArgentinaFil: Kehl, Sebastian Dario. Direcci贸n Nacional de Instituto de Investigaci贸n.Administraci贸n Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbr谩n"; ArgentinaFil: Periolo, Natalia. Direcci贸n Nacional de Instituto de Investigaci贸n.Administraci贸n Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbr谩n"; ArgentinaFil: Azogaray, Viviana. Gobierno de la Provincia de Santa Fe. Ministerio de Salud. Laboratorio Central de la Provincia de Santa Fe.; ArgentinaFil: Casas, Natalia. Ministerio de Salud de la Naci贸n. Programa Nacional de Control de Enfermedades Zoon贸ticas; ArgentinaFil: Ottonelli, Mariano. Gobierno de la Provincia de Santa Fe. Ministerio de Salud. Direcci贸n de Epidemiolog铆a; ArgentinaFil: Bergero, Laura. Consejo Nacional de Investigaciones Cient铆ficas y T茅cnicas. Centro Cient铆fico Tecnol贸gico Conicet - Santa Fe. Instituto de Salud y Ambiente del Litoral. Universidad Nacional del Litoral. Instituto de Salud y Ambiente del Litoral; ArgentinaFil: Cud贸s, Mar铆a Carolina. Gobierno de la Provincia de Santa Fe. Ministerio de Salud. Direcci贸n de Epidemiolog铆a; ArgentinaFil: Previtali, Maria Andrea. Consejo Nacional de Investigaciones Cient铆ficas y T茅cnicas. Centro Cient铆fico Tecnol贸gico Conicet - Santa Fe; Argentina. Universidad Nacional del Litoral. Facultad de Humanidades y Ciencias. Departamento de Ciencias Naturales; ArgentinaFil: Mart铆nez, Valeria P.. Direcci贸n Nacional de Instituto de Investigaci贸n.Administraci贸n Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbr谩n"; Argentin